Last week an FDA panel unanimously recommended rejecting a new drug that’s a combination of morphine and oxycodone – two very strong painkillers. The panel, Anesthetic and Analgesic Drug Products Advisory Committee, said the company didn’t provide data to prove that Moxduo is more effective or safer than using one of the already available drugs.
